BCOP Updates
These modules are designed for practicing advanced level BCOP pharmacists. Covering new and ongoing therapeutic developments, these modules will provide you with up-to-date information, including recently published or ongoing studies from the past 2-3 years that you can immediately apply to your practice. Earn up to 10 hours of BCOP credit.
Individual Learning Opportunities
Clear filter
-
Individual
BCOP Updates 2023: BCMA-Directed Therapy in Relapsed/Refractory Multiple Myeloma: Clinical Trial Updates
On-demand We will analyze the current clinical trials as well as clinical pearls to make patient-specific treatment decisions considering optimal sequencing of therapy. Learn more -
Individual
BCOP Updates 2023: Updates in the treatment of Relapsed/Refractory DLBCL
On-demand This session will review the most updated guidelines; landmark literature on recently-approved agents; and evaluate their potential places in therapy. Learn more -
Individual
BCOP Updates 2023: Frontline Therapy in CLL: Role BTK Inhibitors
On-demand Adverse events and drug interaction management strategies will be discussed during this program. Learn more -
Individual
BCOP Updates 2023: Treatment Updates in mCRPC: PSMA-Directed Therapy
On-demand This session will describe the novel mechanism of action of Lu-177-PSMA-617 and analyze key literature leading to its FDA-approval with an emphasis on safety and efficacy. At the end of this session, participants will be able to identify the role of Lu-177-PSMA-617 in the treatment of mCRPC and understand dosing/administration and access considerations for this treatment option. This session will also review monitoring parameters and side effect management for PSMA-directed therapy. Learn more -
Individual
BCOP Updates 2023: A Changing Landscape in the Treatment of Metastatic Breast Cancer: Targeted Therapy for HER2-low Disease
On-demand This session will focus on FDA-approved and investigational targeted drug therapies for the treatment of HER2-low breast cancer. Learn more -
Individual
BCOP Updates 2023: Colorectal cancer: targeting HER2 and BRAF
On-demand This session will review the pathophysiology of these subsets of colorectal cancer, and will review key clinical trials, targeted therapies, and considerations for therapy selection. Learn more -
Individual
BCOP Updates 2023: Updates in Precision Oncology and the Role of Companion Diagnostics
On-demand Finally, this talk will discuss future opportunities and challenges in this rapidly evolving field of diagnostic testing. Learn more -
Individual
BCOP Updates 2023: The role of immunotherapy in head and neck cancer – current practice and future possibilities
On-demand This presentation will also discuss future roles for immunotherapy in head and neck cancers, by reviewing current literature and on-going studies. Learn more -
Individual
BCOP Updates 2023: Asparaginase Aspirations: Updates in asparaginase products, supportive care and therapeutic drug monitoring
On-demand This session will focus on the new asparaginase products and current literature regarding strategies to limit asparaginase-associated toxicities, including premedication, therapeutic drug monitoring, desensitization, and dose capping. Learn more -
Individual
BCOP Updates 2023: Treatment Updates in Uncommon EGFR Mutations
On-demand This session will review the clinicopathologic characteristics and available therapies for the treatment of these uncommon EGFR mutations. Learn more